Given the clinical and functional significance of KAT2A/E2F1/UBE2C in pan-cancer, we concluded that KAT2A/E2F1/UBE2C and its associated pathway were crucial for cancer carcinogenesis, and targeting this pathway may be pivotal in the prevention or treatment of pan-cancer. The gene discussed is UBE2C; the disease is cancer.